Genetic and pharmacologic manipulation of TLR4 has minimal impact on ethanol consumption in rodents

R. Adron Harris, Michal Bajo, Richard Bell, Yuri A. Blednov, Florence P. Varodayan, Jay M. Truitt, Giordano de Guglielmo, Amy W. Lasek, Marian L. Logrip, Leandro F. Vendruscolo, Amanda J. Roberts, Edward Roberts, Olivier George, Jody Mayfield, Timothy R. Billiar, David J. Hackam, R. Dayne Mayfield, George F. Koob, Marisa Roberto, Gregg E. Homanics

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Toll-like receptor 4 (TLR4) is a critical component of innate immune signaling and has been implicated in alcohol responses in preclinical and clinical models. Members of the Integrative Neuroscience Initiative on Alcoholism (INIA-Neuroimmune) consortium tested the hypothesis that TLR4 mediates excessive ethanol drinking using the following models: (1) Tlr4 knock-out (KO) rats, (2) selective knockdown of Tlr4 mRNA in mouse nucleus accumbens (NAc), and (3) injection of the TLR4 antagonist (+)-naloxone in mice. Lipopolysaccharide (LPS) decreased food/water intake and body weight in ethanol-naive and ethanol-trained wild-type (WT), but not Tlr4 KO rats. There were no consistent genotypic differences in two-bottle choice chronic ethanol intake or operant self-administration in rats before or after dependence. In mice, (+)-naloxone did not decrease drinking-in-the-dark and only modestly inhibited dependence-driven consumption at the highest dose. Tlr4 knockdown in mouse NAc did not decrease drinking in the two-bottle choice continuous or intermittent access tests. However, the latency to ethanol-induced loss of righting reflex increased and the duration decreased in KO versus WT rats. In rat central amygdala neurons, deletion of Tlr4 altered GABAA receptor function, but not GABA release. Although there were no genotype differences in acute ethanol effects before or after chronic intermittent ethanol exposure, genotype differences were observed after LPS exposure. Using different species and sexes, different methods to inhibit TLR4 signaling, and different ethanol consumption tests, our comprehensive studies indicate that TLR4 may play a role in ethanol-induced sedation and GABAA receptor function, but does not regulate excessive drinking directly and would not be an effective therapeutic target.

Original languageEnglish (US)
Pages (from-to)1139-1155
Number of pages17
JournalJournal of Neuroscience
Volume37
Issue number5
DOIs
StatePublished - Feb 1 2017

Fingerprint

Toll-Like Receptor 4
Rodentia
Ethanol
Drinking
Nucleus Accumbens
GABA-A Receptors
Naloxone
Lipopolysaccharides
Genotype
Righting Reflex
Self Administration
Neurosciences
gamma-Aminobutyric Acid
Alcoholism
Eating
Body Weight
Alcohols
Neurons
Messenger RNA
Injections

Keywords

  • (+)-naloxone
  • Chronic intermittent ethanol vapor
  • Drinking-in-the-dark
  • Lipopolysaccharide
  • Operant self-administration
  • Toll-like receptor 4 knock-out

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Harris, R. A., Bajo, M., Bell, R., Blednov, Y. A., Varodayan, F. P., Truitt, J. M., ... Homanics, G. E. (2017). Genetic and pharmacologic manipulation of TLR4 has minimal impact on ethanol consumption in rodents. Journal of Neuroscience, 37(5), 1139-1155. https://doi.org/10.1523/JNEUROSCI.2002-16.2016

Genetic and pharmacologic manipulation of TLR4 has minimal impact on ethanol consumption in rodents. / Harris, R. Adron; Bajo, Michal; Bell, Richard; Blednov, Yuri A.; Varodayan, Florence P.; Truitt, Jay M.; de Guglielmo, Giordano; Lasek, Amy W.; Logrip, Marian L.; Vendruscolo, Leandro F.; Roberts, Amanda J.; Roberts, Edward; George, Olivier; Mayfield, Jody; Billiar, Timothy R.; Hackam, David J.; Mayfield, R. Dayne; Koob, George F.; Roberto, Marisa; Homanics, Gregg E.

In: Journal of Neuroscience, Vol. 37, No. 5, 01.02.2017, p. 1139-1155.

Research output: Contribution to journalArticle

Harris, RA, Bajo, M, Bell, R, Blednov, YA, Varodayan, FP, Truitt, JM, de Guglielmo, G, Lasek, AW, Logrip, ML, Vendruscolo, LF, Roberts, AJ, Roberts, E, George, O, Mayfield, J, Billiar, TR, Hackam, DJ, Mayfield, RD, Koob, GF, Roberto, M & Homanics, GE 2017, 'Genetic and pharmacologic manipulation of TLR4 has minimal impact on ethanol consumption in rodents', Journal of Neuroscience, vol. 37, no. 5, pp. 1139-1155. https://doi.org/10.1523/JNEUROSCI.2002-16.2016
Harris, R. Adron ; Bajo, Michal ; Bell, Richard ; Blednov, Yuri A. ; Varodayan, Florence P. ; Truitt, Jay M. ; de Guglielmo, Giordano ; Lasek, Amy W. ; Logrip, Marian L. ; Vendruscolo, Leandro F. ; Roberts, Amanda J. ; Roberts, Edward ; George, Olivier ; Mayfield, Jody ; Billiar, Timothy R. ; Hackam, David J. ; Mayfield, R. Dayne ; Koob, George F. ; Roberto, Marisa ; Homanics, Gregg E. / Genetic and pharmacologic manipulation of TLR4 has minimal impact on ethanol consumption in rodents. In: Journal of Neuroscience. 2017 ; Vol. 37, No. 5. pp. 1139-1155.
@article{d3233b0aed4f42feb1398e30fca0e377,
title = "Genetic and pharmacologic manipulation of TLR4 has minimal impact on ethanol consumption in rodents",
abstract = "Toll-like receptor 4 (TLR4) is a critical component of innate immune signaling and has been implicated in alcohol responses in preclinical and clinical models. Members of the Integrative Neuroscience Initiative on Alcoholism (INIA-Neuroimmune) consortium tested the hypothesis that TLR4 mediates excessive ethanol drinking using the following models: (1) Tlr4 knock-out (KO) rats, (2) selective knockdown of Tlr4 mRNA in mouse nucleus accumbens (NAc), and (3) injection of the TLR4 antagonist (+)-naloxone in mice. Lipopolysaccharide (LPS) decreased food/water intake and body weight in ethanol-naive and ethanol-trained wild-type (WT), but not Tlr4 KO rats. There were no consistent genotypic differences in two-bottle choice chronic ethanol intake or operant self-administration in rats before or after dependence. In mice, (+)-naloxone did not decrease drinking-in-the-dark and only modestly inhibited dependence-driven consumption at the highest dose. Tlr4 knockdown in mouse NAc did not decrease drinking in the two-bottle choice continuous or intermittent access tests. However, the latency to ethanol-induced loss of righting reflex increased and the duration decreased in KO versus WT rats. In rat central amygdala neurons, deletion of Tlr4 altered GABAA receptor function, but not GABA release. Although there were no genotype differences in acute ethanol effects before or after chronic intermittent ethanol exposure, genotype differences were observed after LPS exposure. Using different species and sexes, different methods to inhibit TLR4 signaling, and different ethanol consumption tests, our comprehensive studies indicate that TLR4 may play a role in ethanol-induced sedation and GABAA receptor function, but does not regulate excessive drinking directly and would not be an effective therapeutic target.",
keywords = "(+)-naloxone, Chronic intermittent ethanol vapor, Drinking-in-the-dark, Lipopolysaccharide, Operant self-administration, Toll-like receptor 4 knock-out",
author = "Harris, {R. Adron} and Michal Bajo and Richard Bell and Blednov, {Yuri A.} and Varodayan, {Florence P.} and Truitt, {Jay M.} and {de Guglielmo}, Giordano and Lasek, {Amy W.} and Logrip, {Marian L.} and Vendruscolo, {Leandro F.} and Roberts, {Amanda J.} and Edward Roberts and Olivier George and Jody Mayfield and Billiar, {Timothy R.} and Hackam, {David J.} and Mayfield, {R. Dayne} and Koob, {George F.} and Marisa Roberto and Homanics, {Gregg E.}",
year = "2017",
month = "2",
day = "1",
doi = "10.1523/JNEUROSCI.2002-16.2016",
language = "English (US)",
volume = "37",
pages = "1139--1155",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "5",

}

TY - JOUR

T1 - Genetic and pharmacologic manipulation of TLR4 has minimal impact on ethanol consumption in rodents

AU - Harris, R. Adron

AU - Bajo, Michal

AU - Bell, Richard

AU - Blednov, Yuri A.

AU - Varodayan, Florence P.

AU - Truitt, Jay M.

AU - de Guglielmo, Giordano

AU - Lasek, Amy W.

AU - Logrip, Marian L.

AU - Vendruscolo, Leandro F.

AU - Roberts, Amanda J.

AU - Roberts, Edward

AU - George, Olivier

AU - Mayfield, Jody

AU - Billiar, Timothy R.

AU - Hackam, David J.

AU - Mayfield, R. Dayne

AU - Koob, George F.

AU - Roberto, Marisa

AU - Homanics, Gregg E.

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Toll-like receptor 4 (TLR4) is a critical component of innate immune signaling and has been implicated in alcohol responses in preclinical and clinical models. Members of the Integrative Neuroscience Initiative on Alcoholism (INIA-Neuroimmune) consortium tested the hypothesis that TLR4 mediates excessive ethanol drinking using the following models: (1) Tlr4 knock-out (KO) rats, (2) selective knockdown of Tlr4 mRNA in mouse nucleus accumbens (NAc), and (3) injection of the TLR4 antagonist (+)-naloxone in mice. Lipopolysaccharide (LPS) decreased food/water intake and body weight in ethanol-naive and ethanol-trained wild-type (WT), but not Tlr4 KO rats. There were no consistent genotypic differences in two-bottle choice chronic ethanol intake or operant self-administration in rats before or after dependence. In mice, (+)-naloxone did not decrease drinking-in-the-dark and only modestly inhibited dependence-driven consumption at the highest dose. Tlr4 knockdown in mouse NAc did not decrease drinking in the two-bottle choice continuous or intermittent access tests. However, the latency to ethanol-induced loss of righting reflex increased and the duration decreased in KO versus WT rats. In rat central amygdala neurons, deletion of Tlr4 altered GABAA receptor function, but not GABA release. Although there were no genotype differences in acute ethanol effects before or after chronic intermittent ethanol exposure, genotype differences were observed after LPS exposure. Using different species and sexes, different methods to inhibit TLR4 signaling, and different ethanol consumption tests, our comprehensive studies indicate that TLR4 may play a role in ethanol-induced sedation and GABAA receptor function, but does not regulate excessive drinking directly and would not be an effective therapeutic target.

AB - Toll-like receptor 4 (TLR4) is a critical component of innate immune signaling and has been implicated in alcohol responses in preclinical and clinical models. Members of the Integrative Neuroscience Initiative on Alcoholism (INIA-Neuroimmune) consortium tested the hypothesis that TLR4 mediates excessive ethanol drinking using the following models: (1) Tlr4 knock-out (KO) rats, (2) selective knockdown of Tlr4 mRNA in mouse nucleus accumbens (NAc), and (3) injection of the TLR4 antagonist (+)-naloxone in mice. Lipopolysaccharide (LPS) decreased food/water intake and body weight in ethanol-naive and ethanol-trained wild-type (WT), but not Tlr4 KO rats. There were no consistent genotypic differences in two-bottle choice chronic ethanol intake or operant self-administration in rats before or after dependence. In mice, (+)-naloxone did not decrease drinking-in-the-dark and only modestly inhibited dependence-driven consumption at the highest dose. Tlr4 knockdown in mouse NAc did not decrease drinking in the two-bottle choice continuous or intermittent access tests. However, the latency to ethanol-induced loss of righting reflex increased and the duration decreased in KO versus WT rats. In rat central amygdala neurons, deletion of Tlr4 altered GABAA receptor function, but not GABA release. Although there were no genotype differences in acute ethanol effects before or after chronic intermittent ethanol exposure, genotype differences were observed after LPS exposure. Using different species and sexes, different methods to inhibit TLR4 signaling, and different ethanol consumption tests, our comprehensive studies indicate that TLR4 may play a role in ethanol-induced sedation and GABAA receptor function, but does not regulate excessive drinking directly and would not be an effective therapeutic target.

KW - (+)-naloxone

KW - Chronic intermittent ethanol vapor

KW - Drinking-in-the-dark

KW - Lipopolysaccharide

KW - Operant self-administration

KW - Toll-like receptor 4 knock-out

UR - http://www.scopus.com/inward/record.url?scp=85011349870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011349870&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.2002-16.2016

DO - 10.1523/JNEUROSCI.2002-16.2016

M3 - Article

C2 - 27986929

AN - SCOPUS:85011349870

VL - 37

SP - 1139

EP - 1155

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 5

ER -